InvestorsHub Logo
Followers 5
Posts 305
Boards Moderated 0
Alias Born 11/28/2020

Re: None

Tuesday, 02/15/2022 8:33:57 AM

Tuesday, February 15, 2022 8:33:57 AM

Post# of 426467
Cost-effectiveness analysis from REDUCE-IT now out. Bottom line, icosapent ethyl is extremely cost-effective in high-risk patients with hypertriglyceridemia despite statins

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789004?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=021522#.Ygumf6oXkN8.twitter
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News